Elevated PAI‐1 levels have been observed to be associated with reinfarction and coronary heart disease (CHD) generally.4 Furthermore, circumventing PAI‐1 actions by administering tissue plasminogen activator, one of the key targets inhibited by PAI‐1, is an important treatment for acute ischemic stroke.5 Here, SERPINE1 is linked to coronary artery disorder.